DNA methylation in urothelial carcinoma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Epigenomics

• Publication date

  2016-09-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/EPI-2016-0064PMID 27624974
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer

  2016cited by this paper
• DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia

  2016cited by this paper
• Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies

  2016cited by this paper
• Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting

  2016cited by this paper
• Enhancer methylation dynamics contribute to cancer plasticity and patient mortality

  2016cited by this paper
• Epigenetic Determinants of Cancer.

  2016cited by this paper
• Gene-specific promoter methylation is associated with micronuclei frequency in urothelial cells from individuals exposed to organic solvents and paints

  2016cited by this paper
• The Impact of DNA Methylation in Hematopoietic Malignancies.

  2016cited by this paper
• Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma.

  2016cited by this paper
• Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

  2016cited by this paper
• Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

  2016cited by this paper
• Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer

  2015cited by this paper
• Genetic alterations of DNA methylation machinery in human diseases.

  2015cited by this paper
• Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise

  2015cited by this paper
• DNA methylation signature in peripheral blood reveals distinct characteristics of human X chromosome numerical aberrations

  2015cited by this paper
• LINE‐1 hypomethylation induced by reactive oxygen species is mediated via depletion of S‐adenosylmethionine

  2015cited by this paper
• Mutation signatures implicate aristolochic acid in bladder cancer development

  2015cited by this paper
• Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.

  2015cited by this paper
• Epigenetic biomarkers in the blood of patients with urological malignancies

  2015cited by this paper
• Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladder.

  2015cited by this paper
• Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems

  2015cited by this paper
• Inter-locus as well as intra-locus heterogeneity in LINE-1 promoter methylation in common human cancers suggests selective demethylation pressure at specific CpGs

  2015cited by this paper
• DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.

  2015cited by this paper
• Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma

  2015cited by this paper
• Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma.

  2015cited by this paper
• Genomic Characterization of Upper Tract Urothelial Carcinoma.

  2015cited by this paper
• Epigenetics of urothelial carcinoma.

  2015cited by this paper
• Quantitative Methylation Analysis of the PCDHB Gene Cluster.

  2015cited by this paper
• An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese

  2015cited by this paper
• EZH2 in Bladder Cancer, a Promising Therapeutic Target

  2015cited by this paper
• Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

  2015cited by this paper
• Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma

  2015cited by this paper
• Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer

  2015cited by this paper
• Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.

  2015cited by this paper
• Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.

  2015cited by this paper
• The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells

  2015cited by this paper
• Inorganic Arsenic-induced cellular transformation is coupled with genome wide changes in chromatin structure, transcriptome and splicing patterns

  2015cited by this paper
• Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors.

  2014cited by this paper
• Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure.

  2014cited by this paper
• Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation.

  2014cited by this paper
• OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro

  2014cited by this paper
• Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma

  2014cited by this paper
• Chromatin repressive complexes in stem cells, development, and cancer.

  2014cited by this paper
• Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

  2014cited by this paper
• The H3K27me3 demethylase UTX in normal development and disease

  2014cited by this paper
• Molecular classification of non-muscle-invasive bladder cancer (pTa low-grade, pT1 low-grade, and pT1 high-grade subgroups) using methylation of tumor-suppressor genes.

  2014cited by this paper
• Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

  2014cited by this paper
• Genotoxic and epigenetic mechanisms in arsenic carcinogenicity

  2014cited by this paper
• Bladder cancers arise from distinct urothelial sub-populations

  2014cited by this paper
• Characterizing DNA methylation alterations from The Cancer Genome Atlas.

  2014cited by this paper
• LINE-1 Hypomethylation in Blood and Tissue Samples as an Epigenetic Marker for Cancer Risk: A Systematic Review and Meta-Analysis

  2014cited by this paper
• What makes a blood cell based miRNA expression pattern disease specific? - A miRNome analysis of blood cell subsets in lung cancer patients and healthy controls

  2014cited by this paper
• A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence

  2014cited by this paper
• Comprehensive molecular characterization of urothelial bladder carcinoma

  2014cited by this paper
• Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors

  2014cited by this paper
• LINE-1 methylation in granulocyte DNA and trihalomethane exposure is associated with bladder cancer risk

  2014cited by this paper
• A global profile of gene promoter methylation in treatment-naïve urothelial cancer

  2014cited by this paper
• HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial Carcinoma

  2013cited by this paper
• Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma

  2013cited by this paper
• Hypermethylation of the polycomb group target gene PCDH7 in bladder tumors from patients of all ages.

  2013cited by this paper
• Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy

  2013cited by this paper
• DNA methylation: roles in mammalian development

  2013cited by this paper
• A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine

  2013cited by this paper
• The CpG island methylator phenotype: what's in a name?

  2013cited by this paper
• Genetic and Non-genetic Predictors of LINE-1 Methylation in Leukocyte DNA

  2013cited by this paper
• TET enzymes, TDG and the dynamics of DNA demethylation

  2013cited by this paper
• HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: Array‐based DNA methylation and expression profiling

  2013cited by this paper
• Alterations of DNA methylome in human bladder cancer

  2013cited by this paper
• DNA methylation-based biomarkers in bladder cancer

  2013cited by this paper
• Diagnostic markers of urothelial cancer based on DNA methylation analysis

  2013cited by this paper
• Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer

  2013cited by this paper
• Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation

  2013cited by this paper
• Normal and neoplastic urothelial stem cells: getting to the root of the problem

  2012cited by this paper
• Functions of DNA methylation: islands, start sites, gene bodies and beyond

  2012cited by this paper
• A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding

  2012cited by this paper
• Long Interspersed Nuclear Element-1 Hypomethylation and Oxidative Stress: Correlation and Bladder Cancer Diagnostic Potential

  2012cited by this paper
• DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status

  2012cited by this paper
• Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns

  2012cited by this paper
• Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.

  2012cited by this paper
• EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

  2012cited by this paper
• Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer

  2012cited by this paper
• Aberrant Methylation of RARβ2 and APC Genes in Voided Urine as Molecular Markers for Early Detection of Bilharzial and Nonbilharzial Bladder Cancer

  2011cited by this paper
• Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events

  2011cited by this paper
• DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer.

  2011cited by this paper
• Increased methylation variation in epigenetic domains across cancer types

  2011cited by this paper
• A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression

  2010cited by this paper
• The implications of heterogeneous DNA methylation for the accurate quantification of methylation.

  2010cited by this paper
• Causes and consequences of DNA hypomethylation in human cancer.

  2005cited by this paper

• Disinfection Byproducts Confirmed over 50 Years: Systematic Curation, Modes of Toxic Action, and Toxicogenomics

  2025cites this paper
• Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillance.

  2025cites this paper
• A urine-based liquid biopsy for detection of upper tract urothelial carcinoma: a self-matched study

  2024cites this paper
• Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma

  2023cites this paper
• Comparison of DNA methylation and cytology tests in urine to detect upper tract urothelial carcinoma: A paired-design diagnostic study.

  2023cites this paper
• Hypermethylated ITGA8 Facilitate Bladder Cancer Cell Proliferation and Metastasis

  2023cites this paper
• The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis.

  2022cites this paper
• DNA methylation-mediated low expression of ZNF582 promotes the proliferation, migration, and invasion of clear cell renal cell carcinoma

  2022cites this paper
• DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma

  2022cites this paper
• Oxidative stress, epigenetics, and bladder cancer

  2021cites this paper
• Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma

  2021cites this paper
• Alterations of Chromatin Regulators in the Pathogenesis of Urinary Bladder Urothelial Carcinoma

  2021cites this paper
• In-Vitro Identification and In-Vivo Confirmation of DNA Methylation Biomarkers for Urothelial Cancer

  2020cites this paper
• Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis

  2020cites this paper
• Molekulare Grundlagen der Karzinogenese und molekularbiologische Untersuchungsmethoden

  2019cites this paper
• Establishment of permutation for cancer risk estimation in the urothelium based on genome-wide DNA methylation analysis.

  2019cites this paper
• Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development

  2019cites this paper
• Methylation of SPARCL1 Is Associated with Oncologic Outcome of Advanced Upper Urinary Tract Urothelial Carcinoma

  2019cites this paper
• Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells

  2019cites this paper
• Oxidative stress and LINE-1 reactivation in bladder cancer are epigenetically linked through active chromatin formation.

  2019cites this paper
• Promoter methylation analysis of CDH1 and p14ARF genes in patients with urothelial bladder cancer

  2018cites this paper
• MicroRNAs in Smoking-Related Carcinogenesis: Biomarkers, Functions, and Therapy

  2018cites this paper
• Molecular Characterization of Bladder Cancer Subtypes

  2018cites this paper
• Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis

  2018cites this paper
• A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer.

  2018cites this paper
• Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer

  2017cites this paper
• DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis

  2016cites this paper